Johnson & Johnson may have planned phantom Tylenol recall

By Parija Kavilanz, senior writer


NEW YORK (CNNMoney.com) -- Johnson & Johnson, which recalled millions of children's Tylenol products earlier this year, may have known of problems and planned to quietly remove those drugs from store shelves months before the official recall, acccording to documents released by lawmakers Thursday.

Lawmakers and drug safety regulators have been investigating successive recalls of Tylenol and other over-the-counter drugs made by Johnson & Johnson's (JNJ, Fortune 500) McNeil Consumer Healthcare unit. In April, McNeil recalled 135 million bottles of children's and infant's Motrin, Tylenol, Benadryl and Zyrtec drugs for quality issues.

A subsequent Congressional investigation revealed that McNeil also tried to conduct a "phantom" recall of more than 88,000 Motrin tablets in June 2009. To conduct the clandestine recall, Johnson & Johnson hired subcontractor WIS to buy up products from store shelves without notifying consumers of the potential problems.

An e-mail dated June 30, 2009 from an executive at WIS indicates the companies were planning a secret recall of children's Tylenol:

"We are exploring another similar but potentially larger recall for July involving children's Tylenol. WIS will look to explore next week the potential quantities in 400 geographically dispersed stores to 'assess' the quantities on shelves ....this across mass, grocery, drug and convenience [stores]. (Wal-Mart (WMT, Fortune 500) is on the list.)"

"J&J could ask Inmar/WIS to move ahead on a scope to purchase product that would make our Motrin project look small." [Inmar is another subcontractor, and was involved in the Motrin recall.]

The e-mail was uncovered as part of the Committee on Oversight and Government Reform's ongoing investigation of Johnson & Johnson.

"This email raises at least two significant questions. First, was Johnson & Johnson's Mr. William Weldon considering conducting a phantom recall of children's medicine?" Committee chairman Edolphus Towns wrote in a letter to Weldon Thursday.

"Second, this email is dated June 30, 2009. Was Johnson & Johnson aware of problems with Children's Tylenol and other children's medicines months before it actually recalled these products?" he asked.

Weldon will get a chance to address these questions later this month. The Committee, which already held one hearing into Johnson & Johnson's drug recalls in May, announced a second hearing to be held on Sept. 30 and has invited Weldon to testify.

Weldon did not testify at the first hearing on May 27. The company was represented then by Colleen Goggins, the chief of its $16 billion consumer products group, which includes McNeil. Separately, Johnson & Johnson announced Thursday that Goggins would retire in May 2011.

Johnson & Johnson would not comment for this report. To top of page

Frontline troops push for solar energy
The U.S. Marines are testing renewable energy technologies like solar to reduce costs and casualties associated with fossil fuels. Play
25 Best Places to find rich singles
Looking for Mr. or Ms. Moneybags? Hunt down the perfect mate in these wealthy cities, which are brimming with unattached professionals. More
Fun festivals: Twins to mustard to pirates!
You'll see double in Twinsburg, Ohio, and Ketchup lovers should beware in Middleton, WI. Here's some of the best and strangest town festivals. Play
Index Last Change % Change
Dow 16,805.41 127.51 0.76%
Nasdaq 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
Treasuries 2.27 -0.00 -0.09%
Data as of 5:59am ET
Company Price Change % Change
Ford Motor Co 13.78 -0.62 -4.31%
Microsoft Corp 46.13 1.11 2.47%
Apple Inc 105.22 0.39 0.37%
Bank of America Corp... 16.72 0.12 0.72%
Yahoo! Inc 43.50 0.90 2.11%
Data as of Oct 24

Sections

New York headlines took a straight forward and direct approach with NYC's Ebola news. More

The midterm elections are around the corner, and the economy remains a top concern. With unemployment down and inflation low, why do people still feel the economy stinks? More

Shares of Facebook recently topped $80. They've more than quadrupled from their post-IPO lows of two years ago. Can Mark Zuckerberg keep the momentum in mobile going? More

Host a furniture market. Here's how small town High Point, N.C. rakes in this much money -- twice a year. More

If you're looking to fly this holiday season, the clock's ticking to get the best prices. More

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.